| Company/Division name | Fujifilm Diosynth Biotechnologies |
| Parent company | FUJIFILM Holdings Corporation |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 450 |
| What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
| Year reshoring announced: | 2022 |
| Capital investment ($): | 1.6 |
| Country(ies) from which reshored: | Japan |
| State(s) reshored to: | TX |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | cell culture |
| What non-domestic negative factors made offshoring less attractive? | Green considerations |
